Skip to main content
Top
Published in: Archives of Virology 7/2015

01-07-2015 | Brief Report

Occurrence and genetic diversity of human cosavirus in influent and effluent of wastewater treatment plants in Arizona, United States

Authors: Masaaki Kitajima, Andri T. Rachmadi, Brandon C. Iker, Eiji Haramoto, Ian L. Pepper, Charles P. Gerba

Published in: Archives of Virology | Issue 7/2015

Login to get access

Abstract

Human cosavirus (HCoSV) is a novel member of the family Picornaviridae. We investigated the prevalence and genetic diversity of HCoSV in influent and effluent wastewater in Arizona over a 12-month period, from August 2011 to July 2012. HCoSV sequences were identified in six (25 %) influent samples and one (4 %) effluent sample, with the highest concentration of 3.24 × 105 and 1.54 × 103 copies/liter in influent and effluent, respectively. The strains were characterized based on their 5’ untranslated region and classified into species A and D, demonstrating that genetically heterogeneous HCoSV were circulating with a clear temporal shift of predominant strains in the study area.
Literature
5.
go back to reference Gerba CP, Kitajima M, Iker BC (2013) Viral presence in waste water and sewage and control methods. In: Cook N (ed) Viruses food water risks, surveillance control. Woodhead Publishing Ltd., Cambridge, pp 293–315CrossRef Gerba CP, Kitajima M, Iker BC (2013) Viral presence in waste water and sewage and control methods. In: Cook N (ed) Viruses food water risks, surveillance control. Woodhead Publishing Ltd., Cambridge, pp 293–315CrossRef
10.
13.
go back to reference Kimura M (1980) A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J Mol Evol 16:111–120PubMedCrossRef Kimura M (1980) A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J Mol Evol 16:111–120PubMedCrossRef
Metadata
Title
Occurrence and genetic diversity of human cosavirus in influent and effluent of wastewater treatment plants in Arizona, United States
Authors
Masaaki Kitajima
Andri T. Rachmadi
Brandon C. Iker
Eiji Haramoto
Ian L. Pepper
Charles P. Gerba
Publication date
01-07-2015
Publisher
Springer Vienna
Published in
Archives of Virology / Issue 7/2015
Print ISSN: 0304-8608
Electronic ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-015-2435-x

Other articles of this Issue 7/2015

Archives of Virology 7/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.